#Tanovea™-CA1

Drug to treat canine lymphoma gets FDA approval

Drug to treat canine lymphoma gets FDA approval

January 3, 2017

VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.

Demo-Cast

Aurora Pharmaceuticals Demo-Cast: Barrier for Dogs

Date: September 25, 2025 1 p.m. ET | 10 a,m, PT
Join us for an informative session with Dr. Pete Hann as we discuss best practices in canine parasite prevention and why a year-round approach matters more than ever. Get insights, ask questions, and help your patients stay protected 365 days a year.
Learn More & Register

All Demo-Casts >
New on
VPN Plus+

Join VPN Plus+ today to get access to exclusive content like:

Understanding and Managing Canine Separation Anxiety: From Diagnosis to Treatment
Understanding and Managing Canine Separation Anxiety: From Diagnosis to Treatment
September pet-related holidays!
September pet-related holidays!
Fire safety isn't optional in veterinary practice
Fire safety isn't optional in veterinary practice
The Behavior Behind the Bite: Medical and Behavioral Insights into Feline Aggression
The Behavior Behind the Bite: Medical and Behavioral Insights into Feline Aggression
Join Now!
VPN Plus+ Store